Joanne A. Hoogerland

Groningen, GR 9713GZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach.

Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach.

Journal: Nutrients

Published: December 18, 2025

Epigenome-wide association study on the plasma metabolome suggests self-regulation of the glycine and serine pathway through DNA methylation.

Epigenome-wide association study on the plasma metabolome suggests self-regulation of the glycine and serine pathway through DNA methylation.

Journal: Clinical epigenetics

Published: December 14, 2023

Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib.

Hepatic ChREBP orchestrates intrahepatic carbohydrate metabolism to limit hepatic glucose 6-phosphate and glycogen accumulation in a mouse model for acute Glycogen Storage Disease type Ib.

Journal: Molecular metabolism

Published: October 27, 2023

Human induced pluripotent stem cell-derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family.

Human induced pluripotent stem cell-derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family.

Journal: Frontiers in pharmacology

Published: May 16, 2023

Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion.

Genetic deletion of hepatic NCOR1 protects from atherosclerosis by promoting alternative bile acid-metabolism and sterol excretion.

Journal: Cardiovascular diabetology

Published: March 02, 2023

Immune-metabolic interactions in homeostasis and the progression to NASH.

Immune-metabolic interactions in homeostasis and the progression to NASH.

Journal: Trends in endocrinology and metabolism: TEM

Published: March 30, 2022

Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.

Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.

Journal: Molecular metabolism

Published: April 09, 2021

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.

Journal: Cellular and molecular gastroenterology and hepatology

Published: September 08, 2020

Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

Journal: Journal of inherited metabolic disease

Published: September 07, 2020

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.

Journal: Human molecular genetics

Published: September 17, 2019

Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.

Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.

Journal: Hepatology (Baltimore, Md.)

Published: July 05, 2019

Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice.

Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice.

Journal: Hepatology (Baltimore, Md.)

Published: August 27, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026